Form 4: Cryoport CEO Jerrell Shelton Exercises Options and Sells Shares Under Pre-Arranged Plan
Insider Transaction Report
Cryoport Inc.'s President and CEO, Jerrell Shelton, exercised stock options and subsequently sold a portion of the acquired common stock through a pre-arranged 10b5-1 trading plan in mid-June 2025.
Summary
- Jerrell Shelton, President, CEO, and Director of Cryoport, Inc., reported multiple transactions involving company common stock and stock options between June 17 and June 20, 2025.
- These transactions included the exercise of stock options at an exercise price of $5.00 per share.
- On June 17, 2025, he exercised options for 50,000 shares, which he retained, resulting in a beneficial ownership of 912,419 shares.
- Additionally, on June 17, 2025, he exercised options for 151,304 shares and simultaneously sold them at a weighted average price of $6.8056 per share.
- On June 18, 2025, he exercised options for 119,281 shares and sold them at a weighted average price of $6.812 per share.
- On June 20, 2025, he exercised options for 69,135 shares and sold them at a weighted average price of $6.4732 per share.
- All sales transactions, totaling 339,720 shares, were conducted automatically pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2025.
- Following these transactions, Mr. Shelton's direct beneficial ownership of Cryoport common stock remains at 912,419 shares, and his remaining stock options (right to buy) decreased to 166,344.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, these transactions were conducted under a pre-arranged 10b5-1 trading plan, which suggests a planned liquidity event rather than a reaction to new negative information. Furthermore, the insider retains a significant beneficial ownership in the company, indicating continued alignment.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, adopted on June 3, 2025, which indicates planned liquidity rather than opportunistic selling based on new, undisclosed information.
- The exercise of stock options at $5.00 per share and subsequent sales at higher weighted average prices (ranging from $6.4732 to $6.812) resulted in a profit for the insider.
- Jerrell Shelton retains a significant direct beneficial ownership of 912,419 common shares and 166,344 stock options, maintaining substantial alignment with shareholder interests.
Negatives
- The sale of a total of 339,720 shares by a key executive, even under a 10b5-1 plan, represents a reduction in direct insider ownership, which can sometimes be perceived negatively by the market.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may observe the insider selling, though the pre-arranged 10b5-1 plan and the insider's continued significant ownership stake mitigate potential negative perceptions.
Key Dates
| Date | Description |
|---|---|
| 08/19/2015 | Start date for option vesting, with 1/48 of options vesting on the 19th of each month for forty-eight months. |
| 06/03/2025 | Date the Rule 10b5-1 trading plan was adopted by Jerrell Shelton. |
| 06/17/2025 | Date of earliest reported transactions: exercise of 50,000 stock options (retained) and exercise/sale of 151,304 shares. |
| 06/18/2025 | Date of transactions: exercise/sale of 119,281 shares. |
| 06/20/2025 | Date of latest reported transactions: exercise/sale of 69,135 shares and filing date of the Form 4. |
| 08/20/2025 | Expiration date for the exercised stock options. |
Keywords
Cryoport, CYRX, insider trading, Form 4, stock options, share sale, executive compensation, Jerrell Shelton, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.